The NCLT ruled that a ₹200 crore future capital infusion must be treated separately from the creditor settlement under the resolution plan approved for Hind Agro.
Separation of Capital Infusion from Creditor Settlement
The National Company Law Tribunal (NCLT) has ruled that a proposed ₹200 crore future capital infusion does not constitute part of creditor settlements within the approved resolution plan for Hind Agro. This delineates a clear framework for understanding capital structuring in insolvency resolutions.
The Tribunal indicated that such capital infusions, while crucial for business continuity, should not be used to offset preexisting debts owed to creditors. The NCLT noted that
"Future capital infusions must be treated distinctly from current creditor settlements to maintain the integrity of the resolution process."This ruling highlights the tribunal's commitment to ensuring that each aspect of a resolution plan maintains its intended purpose and accounting integrity.
This decision is essential for practitioners involved in insolvency as it clarifies the demarcation between operational funding and settlement debts, aiding in structuring viable resolution plans that comply with regulatory standards under the IBC.
Citations
- In re: Hind Agro (2026) NCLT
